Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arnold Lee

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Drugs|July 10, 2021
Correction to: Fuzuloparib: First ApprovalArnold Lee
Drugs|June 18, 2021
Loncastuximab Tesirine: First ApprovalArnold Lee
Drugs|May 8, 2023
Omaveloxolone: First ApprovalArnold Lee
Drugs|December 8, 2025
Rilzabrutinib: First ApprovalArnold Lee
Molecular Diagnosis & Therapy|December 3, 2025
Dorocubicel: First ApprovalArnold Lee
Drugs|November 26, 2025
Paltusotine: First ApprovalArnold Lee
Drugs|May 25, 2025
Vimseltinib: First ApprovalArnold Lee
Targeted Oncology|August 5, 2023
Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate CancerArnold Lee
Drugs|March 21, 2026
Sibeprenlimab: First ApprovalArnold Lee
Drugs|October 15, 2025
Correction: Senaparib: First ApprovalArnold Lee
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Drugs|July 10, 2021
Correction to: Fuzuloparib: First ApprovalArnold Lee
Drugs|June 18, 2021
Loncastuximab Tesirine: First ApprovalArnold Lee
Drugs|May 8, 2023
Omaveloxolone: First ApprovalArnold Lee
Drugs|December 8, 2025
Rilzabrutinib: First ApprovalArnold Lee
Molecular Diagnosis & Therapy|December 3, 2025
Dorocubicel: First ApprovalArnold Lee
Drugs|November 26, 2025
Paltusotine: First ApprovalArnold Lee
Drugs|May 25, 2025
Vimseltinib: First ApprovalArnold Lee
Targeted Oncology|August 5, 2023
Darolutamide: A Review in Metastatic Hormone-Sensitive Prostate CancerArnold Lee
Drugs|March 21, 2026
Sibeprenlimab: First ApprovalArnold Lee
Drugs|October 15, 2025
Correction: Senaparib: First ApprovalArnold Lee
Pageof 10